By Helen Crump2008-11-13T09:00:00
The announcement that patients may top up their NHS care with unapproved treatments means managers face overseeing segregation of patients and tough commissioning decisions. Helen Crump reports
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud